“Analysis of the Effectiveness of the Combination of Bevacizumab and Irinotecan for the Treatment of Glial Tumors”. Research, Society and Development 11, no. 1 (January 9, 2022): e37911125135. Accessed February 19, 2026. https://rsdjournal.org/rsd/article/view/25135.